
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+2
Its time to think again about therapies for neurodegenerative disease. At CuraSen, we are targeting neurodegeneration with novel science and treatments so patients can THINK, AGAIN. CuraSen Therapeutics, Inc. is a privately funded biopharmaceutical company pursuing development of novel treatments for neurodegenerative diseases, including Parkinsons disease and Alzheimers disease, as well as several orphan indications. Millions of patients and their families are burdened by these diseases, and the numbers continue to grow annually with the aging population. At CuraSen, we are rethinking the therapeutic approach to treatment of neurodegenerative diseasesand advancing a concept based on restoring a key functionality to...
Parkinson’s disease,alzheimer’s disease,locus coeruleus,neurodegeneration,neuroinflammation,neurometabolism,and cerebral blood flow
Curasen therapeutics, inc operates in the Biotechnology research industry.
Curasen therapeutics, inc's revenue is 1m - 10m
Curasen therapeutics, inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.